US 11,230,584 B2Granted

Glucagon/GLP-1 agonists for the treatment of obesity

AssigneeMedImmune, LLC

InventorsBalaji Agoram, Madeleine Antonsson, Maria A. Bednarek, Nicole Burmeister, Lambertus Benthem, David Fairman, Maria Fritsch-Fredin, Ronald Jackson, Rasmus Jansson Lofmark, Jacqueline Metcalfe

Life of this patent

Estimating the term…

Abstract

This disclosure provides GLP-1/glue agon agonist peptides for the treatment of metabolic diseases, e.g., obesity.

Claims13

Dependent claims

A pharmaceutical composition comprising:

HSQGTFTSDK(gammaEpalmitoyl)SEYLDSERARDFVAWLEAGG-acid (SEQ ID NO:
17) in combination with a pharmaceutically acceptable carrier suitable for injection.

Dependencies are inferred from the claim text.

Facts

Application: 16/723,645Filed 20 Dec 2019 · continuation
Priority: 11 Dec 2012
Published: US 2020/0115431 A116 Apr 2020
Granted: 25 Jan 2022
Term ends: Not estimatedThe source records don’t support an estimate.

Classification6 codes

C07K 14/605
Hormones: glucagons
A61P 3/04
Drugs for disorders of the metabolism: anorexiants; Antiobesity agents
A61K 38/00
Medicinal preparations containing peptides
C07K
Peptides

Family

Application61/735,823Us provisional application · filed 11 Dec 2012
PCT/IB2013/003191Parent of this division · filed 10 Dec 2013
Application15/673,826Parent of this continuation · filed 10 Aug 2017
US 9,765,130 B2Parent of this division · filed 19 Sep 2017
US 2020/0115431 A1Pre-grant publication · published 16 Apr 2020
US 10,556,939 B2Parent of this continuation
Application14/650,469Parent of this division
Application15/673,826Parent of this division
US 2015/0307579 A1Published application
US 2017/0342121 A1Published application
US 11,230,584 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results